Product Images Lyrica
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 20 images provide visual information about the product associated with Lyrica NDC 54868-5550 by Physicians Total Care, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PRINCIPAL DISPLAY PANEL - 100 mg Capsule Bottle - 100mg package label
PRINCIPAL DISPLAY PANEL - 150 mg Capsule Bottle - 150mg package label
PRINCIPAL DISPLAY PANEL - 200 mg Capsule Bottle - 200mg package label
This is a prescription drug label for Lyrich 26646 4P G, with an NDC number of 54868-6063-1. It was distributed by Physicians Total Care and is a 400 mg extended-release tablet. However, there seems to be some inaccurate and incomplete information in the text.*
PRINCIPAL DISPLAY PANEL - 25 mg Capsule Bottle - 25mg package label
PRINCIPAL DISPLAY PANEL - 50 mg Capsule Bottle - 50mg package label
PRINCIPAL DISPLAY PANEL - 75 mg Capsule Bottle - 75mg package label
The text is a logo or a phrase that reads "PHYSICIANS,| TOTAL CARE". A description cannot be generated based on this text alone.*
Figure - lyrica 01
This is a medical formula to calculate the creatinine clearance rate for female patients. It involves subtracting the age of the patient from 140, multiplying the result by the patient's weight in kilograms, and multiplying that result by the serum creatinine level in mg/dL. The output is then divided by 72 and multiplied by 0.85 for female patients.*
Chemical Structure - lyrica 02
Figure 1 - lyrica 03
Figure 2 - lyrica 04
Figure 3 - lyrica 05
Figure 4 - lyrica 06
Figure 5 - lyrica 07
This text appears to be a chart or table displaying the percentage of improvement in pain from baseline for patients who received different treatments, including Pregatalin 100 mg three times a day, Pregabalin 0 mg three times a day, and Placeta. However, the characters in the text are garbled and unreadable, making it difficult to provide a more complete description.*
Figure 6 - lyrica 08
Figure 7 - lyrica 09
Figure 8 - lyrica 10
Figure 9 - lyrica 11
Figure 10 - lyrica 12
Figure 11 - lyrica 13
The data shows the percentage of subjects who experienced improvement after taking Pregabalin compared to Placebo. The percentage of subjects who experienced improvement was 100%. Graphical data is also available for reference.*
Logo - lyrica 14
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.